×

RNS Number : 5412G

Trakm8 Holdings PLC

31 May 2017

 

31 May 2017

TRAKM8 HOLDINGS PLC

 

("Trakm8" or the "Group")

 

Iceland Foods Awards Trakm8 Optimisation & Telematics Contract Extension

 

 

Trakm8, the AIM-listed telematics and data provider to the global market place, is pleased to announce it has been awarded a contract extension by Iceland Foods Limited, the UK's leading frozen food retailer.

 

The contract extension covers the provision of Trakm8's Route Monkey Optimisation software and updates Trakm8's Roadsense telematics with Trakm8's latest "RoadHawk 600" integrated 4G video and telematics solution, with data provided via Trakm8's latest data solution "Insight". The new contract extension will run until April 2024.

 

Trakm8, through Route Monkey and Roadsense, has been providing solutions for over 1,500 Home delivery vehicles and optimising over 11 million deliveries per year. The next generation solutions will provide even better optimisation of these deliveries, far better insights into how the vehicles are being driven and the vehicle service requirements. The solutions will be fully integrated within the Trakm8 software and Iceland's EPOS.

 

John Watkins, Executive Chairman of Trakm8 commented: 

"We have been working with Iceland Foods for over four years providing optimisation and telematics solutions. Iceland is a market leader in adopting new technology and we are delighted that it is the first significant customer for our next generation integrated products and solutions.

 

"It is validation of the acquisitions of both Route Monkey & Roadsense and Trakm8's product strategy to integrate Optimisation, Camera and Telematics technologies.

 

"This is a long term contract that provides predictable revenues for the years ahead."

 

-ends-

 

For further information please contact:

 

Trakm8 Holdings plc	+44 (0) 174 785 8444
John Watkins, Executive Chairman
James Hedges, Finance Director
finnCap (Nomad and broker)	+44 (0) 20 7220 0500
Ed Frisby / Simon Hicks – corporate finance
Tim Redfern / Richard Chambers – corporate broking
MHP Communications	+44 (0) 20 3128 8100
Reg Hoare / Charlie Barker

About Trakm8

Trakm8 is a UK based technology leader in fleet management, insurance telematics, optimisation and dashboard camera systems. Through IP owned technology, the Group analyses data collected by its installed base of telematics units to fine tune the algorithms that are used to produce its telematics based solutions; these score driver behaviour, monitor vehicle health and continuously improve the security and operational efficiency of both private drivers and company fleets.

 

The Group's product portfolio includes cameras (including the recently launched integrated telematics camera), self-installed telematics units and technology to eliminate distracted driving due to mobile phones, and it has over 191,000 installed units reporting to its servers. 

 

Headquartered in Dorset with a manufacturing facility in the West Midlands, the Group supplies, through its dedicated business units Fleet, Optimisation, Insurance and Automotive, many well-known customers in the UK and internationally including the AA, Saint Gobain, EON, Direct Line Group and Young Marmalade.

 

Trakm8 has been listed on the AIM market of the London Stock Exchange since 2005.

 

www.trakm8.com / @Trakm8

 

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

CNTFMGFKLGNGNZG

Close

×

RNS Number : 4310G

Crimson Tide PLC

30 May 2017

 

Crimson Tide PLC

("Crimson Tide" or the "Company")

International Expansion Update

Crimson Tide (TIDE), the AIM‐quoted provider of mpro5 ‐ Smart Mobility as a Service, is pleased to update the market on progress with its international expansion strategy, which it has previously indicated will drive further growth opportunities. Strategic partnerships with tactical investments are being made in new geographies, complementing the organic growth being delivered in the UK.

Particular areas of progress are as follows:

 

 

·     Ireland – first phase contract secured with one of the largest state-sponsored companies in Ireland. The initial agreement is for approximately 200 subscribers who will be using mpro5 for remote working. This transaction has been closed with the Company's partner, Vodafone. To support the ongoing growth in Ireland, Wesley Dunn has been promoted to a full time role in Business Support.

 

·     United States –  Dagen Wilhelm has been appointed as International Healthcare Consultant. Ms. Wilhelm, based in the Washington D.C. area, will focus on business development for mpro5 with specific emphasis on the Company's healthcare offering. Dagen will be the key contact for our participation in the CARIN Allliance, which focuses on delivering solid pharmacovigilance and digitalised healthcare. The CARIN Alliance is a bipartisan, multi-sector collaborative, working to advance consumer-directed exchange of health information.  Further to this, Crimson Tide is also in the process of establishing membership of RX360 – an international Pharmaceutical Supply chain consortium.

 

·     Netherlands – Following the recruitment of Erik-Jan Smulder, a seasoned sales professional previously with BlackBerry, the Company has signed an important pilot project with one of the world's leading Facilities Management companies, based in The Netherlands, which is looking to combine mpro5's smart mobility with Internet of Things ("IoT") enabled functionality. The pilot has commenced and the Company is hopeful that this will lead to a long term commercial agreement in the near future.

 

·     Denmark – The Company has secured its first contract with a Scandanavian company with a global footprint involved in the food processing industry. The use of mpro5 will enable staff to check workflows as components move through the supply chain. The initial deployment is small but expected to increase as the benefits of mpro5 are recognised.

 

·     UAE – our agreement with the British Centres for Business, ("BCB") has started to produce Enterprise level opportunities to the extent that we are pleased to announce the appointment of Senior Consultant Brad Manser with immediate effect. Mr. Manser, who is based in Dubai, will act as Director of Business Development for the Middle Eastern region. Brad has a wealth of experience in the area with previous roles as Operations Manager, Chief Operating Officer and Managing Director for a number of companies within the region.

 

·     Australia. The Company has got off to a good start with its new partner, Mobilise IT , based in Melbourne and will be visiting the region shortly to progress emerging opportunities. 

 

The Company is also pleased to announce the appointment of Barry Finnegan, an IoT strategist who will help develop our nascent investment in IoT technologies on mpro5. IoT has considerable benefits for intelligent and proactive data collection, particularly regarding smart sensors from motion to temperature & humidity, and Bluetooth devices which, we believe, represents a significant opportunity for mpro5 and Crimson Tide.

Barrie Whipp, Executive Chairman of Crimson Tide, said: "We are delighted with the progress that we have made with our international sales effort in such a short space of time and which underpins our belief that mpro5 has wide reaching appeal on a global basis. This is just the start of our international journey and I am confident that we will experience many more successes and wide scale adoption in these and other geographies as our reputation continues to grow."

For further information please contact:

 

Crimson Tide plc Barrie Whipp / Steve Goodwin	01892 542 444
WH Ireland James Joyce / James Bavister	020 7220 1666
Alma PR Josh Royston / Robyn Fisher	O77 8090 1979 / 075 4070 6191

 

Notes to editors

1. Founded in 1996 and quoted on AIM since 2006, Crimson Tide plc is the provider of mpro5 ‐ Smart Mobility as a Service (SMaaS). mpro5 is delivered on smartphones, tablets and PDAs, and enables companies to transform their businesses and strengthen their workforces.

2. Crimson Tide offers a global service, working with some of the world's leading companies, tailoring mpro5 to suit customer needs. Developed over 10 years by its world‐class team, mpro5 is the smart choice for organisations large and small that want to improve productivity and save money.

3. mpro5 is a platform‐agnostic mobility suite fully hosted on Microsoft Azure, so customers are quickly up and running and the service is scalable and robust. It is provided on subscription, so clients can immediately see a return on their investment.

4. mpro5 not only helps people improve their day‐to‐day working methods while saving employers money, it also saves lives, by enabling haemophilia patients to verify the safety of their medication before use. mpro5 clients come from a diverse range of industries allowing the Company to listen, share and find the best solution for all mobility needs.

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCBUGDULBDBGRL

Close

×

Neville Registrars is delighted to welcome Solid State PLC as the newest addtion to its list of client companies.

Solid State PLC is a high value-add manufacturer and specialist design-in distributor to the electronics industry. It has particular expertise in computing technologies, electronic components, secure communications and batteries. Typical clients operate in aerospace, environmental, government, oil & gas and transportation markets.

Further information can be found on the Company's website: https://www.solidstateplc.com/

Close

×

RNS Number : 1728G

World Trade Systems PLC

24 May 2017

 

World Trade Systems PLC

17 May 2017

 

WORLD TRADE SYSTEMS PLC ("WTS") 

 

17th May 2017

 

WTS plc announces that it has entered into a memorandum of understanding ("MOU") in connection with a commercial cooperation agreement with a well-established international company that aligns with the overarching goals and vision of WTS plc.  The Board of WTS believes that this will result in the expansion of the business of WTS China by diversifying its product range and extending its market reach. R&D and market distribution co-operation with Biestmilch GmbH ("Biestmilch")

WTS plc has entered into an MOU with 'Biestmilch' which was founded in 1999 by Dr Susann Kraftner , based in Lindau, Germany. 

Dr Susann Kraftner and Dr Arne Schumacher are the current Managing Directors. Dr Kraftner has over 19 years' experience in the development of Biestmilch products. She is also an author and medical doctor with experience of working in pharmaceutical organisations.

Beistmilch has already developed promising high end products for immune system performance and anti-depression chewable tablets with excellent results. Biestmilch has established their tested and effective products including the chewable tablets, to assist with immunity and the conditions of stress. Beistmilch's booster tablets have been described as "kicks in stronger than coffee while boosting your immunity at the same time". Biestmilch's object is to create a market leading brand of biological body immunity boost food.

WTS plc believes that through close collaboration with Biestmilch we can pool market knowledge and R&D resources to help both companies achieve synergistic benefits by distributing new healthcare and cell based products in an international market.

 

 WTS plc will seek any necessary authorities in due course.

 

For more information, please contact the following:

World Trade Systems plc

Mr. Shao Chen, Vice Chairman, shaochen@wtscn.com

Mr. AKM Ismail, Executive Director, akm.ismail@gmail.com

 

Information on WTS plc

WTS plc is a health food products company that develops, manufactures and distributes health food products targeted at mid/high end consumers. Having previously had no business activities for a number of years, the Company began its current business activities in July of 2016 and is in the process of applying for a re-listing of its shares on the Standard Segment of the Official List of the Financial Conduct Authority.

Information on WTS China

Based on its expertise in the Chinese health food industry, with a focused product strategy, a progressive marketing plan, and in depth understanding of consumer trends, WTS China aims to become a comprehensive health food solution provider. WTS China is located in Suzhou, Jiangsu Province, in the central part of eastern China.

WTS China's current health drinks use collagen and other natural ingredients aimed at providing consumers with healthy food supplements containing nutrients which aim to support the body's immune system, improve digestion, lower cholesterol and blood pressure and promote healthier organ functions, smoother and more elastic skin and better complexion. WTS China is active in R&D developing additional products.

WTS China's  vision is to become a leading player in distributing many high quality health food products throughout China.

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

STREAESLAEDXEAF

Close

×

RNS Number : 0136G

Trakm8 Holdings PLC

24 May 2017

 

24 May 2017

TRAKM8 HOLDINGS PLC

 

("Trakm8" or the "Group")

 

Roadside Assistance Technology Company Awards Trakm8 Telematics Contract

 

 

Trakm8, the AIM-listed telematics and data provider, is pleased to announce it has been awarded an initial contract by a roadside assistance technology company, to supply devices and data.

 

The initial contract includes a number of devices for the initial launch, along with integration engineering fees.

 

The contract is for launch in July 2017 to the customer's roadside assistance partners in Europe.  The initial focus will be in the UK and Holland. It is expected that the solution will be extended to other European markets in due course.

 

Trakm8 will provide its latest generation Connect 300 plug in telematics device. Data supplied will be from the Trakm8connectedcare solution to monitor the vehicle health and usage based on Trakm8's extensive automotive diagnostic knowledge.

 

 

John Watkins, Executive Chairman of Trakm8 commented: 

"We are delighted to win another customer for Trakm8's automotive telematics solutions. We have been providing telematics on extended trial with our Trakm8connectedcare product for about 12 months. It is also encouraging that this solution is expected to be offered in multiple countries.

 

"This contract is expected to be a significant one and provides additional visibility for our expectations for this financial year and beyond."

 

 

-ends-

 

For further information please contact:

 

Trakm8 Holdings plc	+44 (0) 174 785 8444
John Watkins, Executive Chairman
James Hedges, Finance Director
finnCap (Nomad and broker)	+44 (0) 20 7220 0500
Ed Frisby / Simon Hicks – corporate finance
Tim Redfern / Richard Chambers – corporate broking
MHP Communications	+44 (0) 20 3128 8100
Reg Hoare
Charlie Barker

 

About Trakm8

Trakm8 is a UK based technology leader in fleet management, insurance telematics, optimisation and dashboard camera systems. Through IP owned technology, the Group analyses data collected by its installed base of telematics units to fine tune the algorithms that are used to produce its telematics based solutions; these score driver behaviour, monitor vehicle health and continuously improve the security and operational efficiency of both private drivers and company fleets.

 

The Group's product portfolio includes cameras (including the recently launched integrated telematics camera), self-installed telematics units and technology to eliminate distracted driving due to mobile phones, and it has over 191,000 installed units reporting to its servers. 

 

Headquartered in Dorset with a manufacturing facility in the West Midlands, the Group supplies, through its dedicated business units Fleet, Optimisation, Insurance and Automotive, many well-known customers in the UK and internationally including the AA, Saint Gobain, EON, Direct Line Group and Young Marmalade.

 

Trakm8 has been listed on the AIM market of the London Stock Exchange since 2005.

 

www.trakm8.com / @Trakm8

 

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

CNTUOSSRBSAVUAR

Close

×

RNS Number : 0154G

SpaceandPeople PLC

24 May 2017

 

24 May 2017

SpaceandPeople plc

Prestigious Property Win

SpaceandPeople has signed an exclusive contract with British Land for experiential marketing and outdoor opportunities in their London portfolio of venues

SpaceandPeople (AIM: SAL), the retail, promotional and brand experience specialist, is pleased to announce it has commenced an exclusive multi-year contract to manage the promotional space across British Land's portfolio of outdoor public spaces in London.

Having entered an exclusive contract with British Land during 2015 to manage the promotional space across their shopping centre and outdoor shopping park portfolios, they have now extended this agreement to include their London outdoor venues.

These venues include the prestigious Broadgate, Paddington Central and Regent's Place.

Matthew Bending, SpaceandPeople CEO, said:

"This is a significant endorsement of SpaceandPeople, with a major client choosing to extend their relationship with us to include a number of the most prominent public spaces in London."            

Contact details: 

SpaceandPeople Plc	0845 241 8215
Matthew Bending, Gregor Dunlay
Cantor Fitzgerald Europe	020 7894 7000
David Foreman, Will Goode (Corporate Finance)
Alex Pollen (Sales)

 

About SpaceandPeople

SpaceandPeople facilitates and manages promotional space for marketing campaigns and retailing in shopping centres, railway stations, retail parks, airports and other high footfall locations. SpaceandPeople is at the forefront of developing the concept of space as an advertising and promotional medium. It offers consumer brands the opportunity to promote their products through direct engagement with consumers through a mix of experiential marketing events and complementary above the line advertising and multimedia campaigns. SpaceandPeople offers a comprehensive service covering brokerage, consultancy and venue centric media buying. SpaceandPeople is independently funded and its shares are admitted to trading on AIM. The Company operates in the UK and Germany and also in India.

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

NRAOKNDKPBKDQPB

Close

×

RNS Number : 7329F

Nanoco Group PLC

22 May 2017

 

                                                                                                            

                   Nanoco and Kyulux Inc. Sign Agreement to Develop Next Generation Displays

 

The creation of Cadmium-Free Quantum Dot Hybrid QLED – OLED Technology Offers the Potential of Vastly Superior Displays

MANCHESTER, UK & CONCORD, Mass. USA, 22 May 2017 – Nanoco Group plc (LSE: NANO), a world leader in the development and manufacture of cadmium-free quantum dots and other nanomaterials, and Kyulux Inc., a world leader in developing and delivering the next generation of organic light emitting diode (OLED) technology today announced the signing of a collaboration and joint development agreement.

Under the agreement, Nanoco's heavy metal free quantum dots (CFQD quantum dots) will be combined with Kyulux's Hyperflourescent 'thermally activated delayed fluorescence' ("TADF") technology to create future generation hybrid OLED / QLED display technology with  superior qualities to existing products in the display market.

In addition to offering a high degree of brightness and pure color, the combination of technologies means the displays will be cost effective for manufacturers and highly energy efficient for consumers.

"We are excited by the potential of this partnership, which brings together two global leaders in their fields," said Nanoco's Chief Executive Officer Michael Edelman. "By combining the best of quantum dot technology with the best of new generation OLED technology, we will bring world-class display technology to market.  We have great confidence in our ability to deliver our current technology to the display market as planned.  Innovation is core to Nanoco and this partnership complements our existing strategy to deliver cutting edge technology to the display market without increasing our cash burn."

 

"Kyulux is delighted to collaborate with Nanoco on this project, which will produce a vast improvement in display technology," said Christopher Savoie, Chief Executive Officer of Kyulux Inc. "As well as enhancing brightness and color, our next generation of display devices will be both cost effective and highly energy efficient.  This will offer a technology breakthrough, particularly in the manufacture of ultra-high definition large screen devices."

 

Under the terms of the agreement, Nanoco and Kyulux will jointly develop and market this future display technology.

ABOUT KYULUX

Kyulux is a leader in developing and delivering the next generation of organic light emitting diode (OLED) technology, TADF. Kyulux develops and sells TADF and Hyperfluoresence based OLED materials and solutions to manufacturers in the display and lighting industries.

 Founded in 2015, the Company currently owns or has exclusive, co-exclusive or sole license rights to a large TADF intellectual property portfolio developed over the past seven years at Kyushu University and its industrial partners. Kyulux also enjoys a license to cutting-edge deep learning-based artificial intelligence technology for chemical discovery developed at Harvard University.

 Kyulux's cofounder and the inventor of TADF technology, Prof. Chihaya Adachi, is widely viewed as the top global researcher in OLED technology, having been a key author and inventor in all previous generations of OLED materials that are now used everyday by consumers across the globe.

Based in Fukuoka, Japan, with an advanced research and development center in Boston, Massachusetts.  For further information please visit:  www.kyulux.com

ABOUT NANOCO

Nanoco (LSE: NANO) harnesses the power of nano-technology to create a brighter, more sustainable future. Based on breakthrough science, Nanoco's proprietary manufacturing process enables the large-scale production of its cadmium-free CFQD® quantum dots for multiple applications:

·     LCD display, where Nanoco's CFQD® quantum dots give consumers peace of mind to enjoy next-generation color performance and energy efficiency without allowing toxic chemicals into their homes.

·     Lighting, where Nanoco's CFQD® quantum dots are used in horticulture to safely speed plant growth.

·     Healthcare, where Nanoco's CFQD® quantum dots are opening new, potentially life saving uses in bio-imaging.

·     Solar, where Nanoco's CFQD® quantum dots are incorporated into printable solar inks for future thin, highly efficient and low cost solar cells.

 

Nanoco has non-exclusive manufacturing and marketing licensing agreements in display with The Dow Chemical Company, Merck KGaA of Germany, and Wah Hong Industrial Corporation of Taiwan. Through these partners and its own production facilities in Runcorn, UK, Nanoco is creating the world's largest manufacturing ecosystem for cadmium-free quantum dots.

 

Nanoco was founded in 2001 and is headquartered in Manchester, UK, with a US subsidiary, Nanoco Inc., in Concord, MA. Nanoco continues to build out a world-class, patent-protected IP portfolio generated both by its own innovation engine, as well as through acquisition. 

 

Nanoco is listed on the main market of the London Stock Exchange and trades under the ticker symbol NANO.  For further information please visit: www.nanocogroup.com.

 

For further information, please contact:

 

MHP Communications	Tel: +44 (0) 20 3128 8788
Reg Hoare / Andrew Leach / Giles Robinson nanoco@mhpc.com

 

 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

NRASFSFMUFWSELI

Close

×

RNS Number : 7028F

Water Intelligence PLC

22 May 2017

 

 

 

Water Intelligence plc ("Water Intelligence" or the "Company")

American Pool Enterprises Agreement

 

Water Intelligence plc announces the signing and launch of the Company's first formal national partnership for pool leak detection and repair between its core brand – American Leak Detection – and American Pool Enterprises.

 

American Pool is the largest commercial swimming pool management, maintenance, construction and recreational facility management operation in the United States. American Pool operates in 16 U.S. states and Washington DC with an international location in Toronto, Ontario Canada.  American Leak Detection is the leading minimally invasive water leak detection and repair company in the United States with corporate and franchise operations in 42 states and Washington D.C. with international operations in Toronto and Alberta, Canada as well as in Australia and the UK. Pool leak detection and repair has been part of the core service offering of American Leak Detection since its founding. Both companies were founded in 1984.

 

Because of American Pool's business scope, American Leak Detection will use the same execution protocols that it has with national insurance company customers in order to provide American Pool with priority service.  American Pool Enterprises serves over 3,000 commercial swimming facilities and over 9,400 residential pools. The commercially-focused business serves apartments, homeowner associations, country clubs, swim clubs, hospitality businesses, condominiums, fitness clubs and active adult communities.

 

Patrick DeSouza, Executive Chairman of Water Intelligence plc commented, "Our business to business approach will leverage our existing US and Canadian footprint both to provide a full range of solutions to the problem of water loss and to reduce administrative costs for American Pool.  We are excited about the opportunity to work with the leading company in pool management. We share the same customer-centric values."

 

Daniel Lawler, Chief Operating Officer for American Pool Enterprises states, "We have always conducted business with the philosophy that our clients deserve the absolute best in safety and service. I am excited that we have established a relationship that does just that. We are now able to present supplementary solutions to our customers, satisfying the high demand during our peak season.   

 

Enquiries:  

Water Intelligence plc            Patrick DeSouza, Executive Chairman	T: +1 203 654 5426
finnCap Ltd Adrian Hargrave / Giles Rolls, corporate finance Stephen Norcross, corporate broking	T: +44 (0) 207 220 0500
American Pool Enterprises, Inc. Dan Lawler, Chief Operating Officer	T: 443-471-1190 dlawler@americanpool.com

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

AGRSFSFDUFWSEFI

Close

×

RNS Number : 7403F

Midatech Pharma PLC

22 May 2017

 

 

 

 

22 May 2017

Midatech Pharma PLC

("Midatech", "Company" or "Group")

 

Midatech announces progress update on brain cancer therapies

 

Midatech Pharma (AIM: MTPH, Nasdaq: MTP), the international specialty pharmaceutical company focused on developing and commercialising products in oncology, announces that it has selected its preferred candidate for testing in glioblastoma (GBM) brain cancer.  The compound is under final evaluation with some key pre-clinical studies to confirm efficacy before being progressed into IND enabling trials and thereafter full development studies. Additional candidates are also being evaluated in parallel.

 

The GBM candidate is based on Midatech's gold nanoparticle technology which aims to improve the delivery of currently marketed drugs to be specifically targeted at the tumour cells while sparing healthy tissue, thereby reducing side effects and enhancing efficacy. Worldwide, it is estimated that there are 240,000 cases of brain and nervous system tumours per year, of which GBM is the most common and the lowest survival rate, typically only 12 to 15 months.

 

Midatech has a portfolio of brain cancer product candidates that are being developed with the goal of treating brain tumours via either systemic administration and crossing the blood brain barrier (BBB); and/or via intra-tumoural administration using a convection enhanced delivery technique that bypasses the BBB and delivers therapies directly into the tumour.

 

Midatech is developing MTX110, a potential treatment for DIPG (diffuse intrinsic pontine glioma), an ultra-rare childhood brain cancer for which there is currently no satisfactory treatment. Patients' average survival time is currently just 7-9 months. Clinical trials with MTX110 are expected to start in H2 2017 and, following requests from DIPG physicians, the product has also been made available on a compassionate use basis with several patients under treatment.  Brainstem tumours comprise approximately 10-15% of all paediatric brain tumours, of which the most common subtype (80%) is DIPG estimated to affect 2.5 per 1,000,000 patients in the US and EU annually.

 

Commenting on this progress, Jim Phillips, CEO of Midatech Pharma, remarked: "Midatech is developing a range of product candidates for patients using potentially improved forms of cancer therapies.  Midatech's objective is to maximise tumour shrinkage effects while minimising effects on normal cells through its 'right place, right time' technology.  The selection of a preferred candidate to treat glioblastoma is an important milestone as we look to advance our products into the clinic for challenging cancers for which patients currently have a very poor prognosis."

 

– Ends –

 

For more information, please contact:

 

Midatech Pharma PLC

Jim Phillips, CEO

Tel: +44 (0)1235 841575

www.midatechpharma.com

 

Panmure Gordon (UK) Limited (Nominated Adviser and Broker)

Corporate Finance

Freddy Crossley / Duncan Monteith

Broking

Tom Salvesen

Tel: +44 (0)20 7886 2500

 

Consilium Strategic Communications (Financial PR)

Mary Jane Elliott / Ivar Milligan / Cameron Standage

Tel: +44 (0)20 3709 5700

Email: midatech@consilium-comms.com

 

Westwicke Partners (US Investor Relations)

Chris Brinzey

Tel: +1 339 970 2843

Email: chris.brinzey@westwicke.com

 

Notes for Editors

 

About Midatech Pharma PLC

 

Midatech is an international specialty pharmaceutical company focused on oncology with a US commercial operation marketing four cancer care supportive products, and co-promoting two others. Midatech's strategy is to internally develop oncology products and collaborate with partners, and to drive growth both organically and through strategic acquisitions. The Company's R&D activities are supported by two breakthrough drug delivery technologies: Q-Sphera for sustained release and our proprietary gold nanoparticles. The Group, listed on AIM: MTPH and Nasdaq: MTP, employs c.110 staff in four countries. For further company information see: www.midatechpharma.com

 

 

Forward-Looking Statements

Certain statements in this press release may constitute "forward-looking statements" within the meaning of legislation in the United Kingdom and/or United States, including (without limitation) those regarding the Group's financial position, business strategy, products, plans and objectives of management for future operations, and any statement preceded or followed by, or including, words such as "target", "believe", "expect", "aim", "intend", "will", "may", "anticipate", "would" or "could", or negatives of such words. Any forward-looking statements are based on currently available competitive, financial and economic data together with management's views and assumptions regarding future events and business performance as of the time the statements are made and are subject to risks and uncertainties. We wish to caution you that there are some known and unknown factors that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements.

 

Reference should be made to those documents that Midatech shall file from time to time or announcements that may be made by Midatech in accordance with the London Stock Exchange AIM Rules for Companies ("AIM Rules"), the Disclosure and Transparency Rules ("DTRs") and the rules and regulations promulgated by the US Securities and Exchange Commission, which contains and identifies other important factors that could cause actual results to differ materially from those contained in any projections or forward-looking statements. These forward-looking statements speak only as of the date of this announcement. All subsequent written and oral forward-looking statements by or concerning Midatech are expressly qualified in their entirety by the cautionary statements above. Except as may be required under the AIM Rules or the DTRs or by relevant law in the United Kingdom or the United States, Midatech does not undertake any obligation to publicly update or revise any forward-looking statements because of new information, future events or otherwise arising.

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

NRAABMBTMBTTTFR

Close

×

RNS Number : 5368F

LightwaveRF PLC

18 May 2017

 

18 May 2017

LightwaveRF Plc

(AIM: LWRF)

 

LightwaveRF launch Google Assistant voice control for Google Home

 

LightwaveRF plc ("LightwaveRF" or the "Company"), the leading smart home solutions provider for the remote control and monitoring of light, heat, power and security through a wide range of devices via just one app, is pleased to announce the launch of Google Assistant voice control for Google Home across the LightwaveRF product range.

 

Since the launch of the Google Home hands-free smart speaker in the UK last month, LightwaveRF has been working closely with Google to achieve Google Assistant voice control for the LightwaveRF product range. This has been achieved and launched to the LightwaveRF user base today as well as being featured at Google I/O, the annual worldwide developer festival being held this week in Mountain View, California.

 

Commenting, Andrew Pearson, CEO said: "We are continuing to invest in building our cloud platform and our innovative approach allows us to quickly integrate with major connected home brands and devices to achieve high quality results.  Voice control is now widely accepted as a key enabler for smart home solutions and drives both new customer acquisition and new device sales to existing customers for the Company.  The expansion of LightwaveRF's voice control through this addition greatly improves the user experience for Google and LightwaveRF customers.  It is a testament to the quality of our technology that LightwaveRF is amongst the launch group of smart home partners for Google Home."

 

This announcement includes inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 and is disclosed in accordance with the Company's obligations under Article 17 of those Regulations.

 

 

For further information:

Contacts:
LightwaveRF plc	www.lightwaveRF.com
Andrew Pearson, CEO	+44 (0) 121 250 3625
Kevin Edwards, CFO
WH Ireland Limited	www.whirelandplc.com
Mike Coe/Ed Allsopp (Corporate Finance)	+44 (0) 117 945 3470
Jasper Berry (Institutional Sales)	+44 (0) 20 7220 1666
Yellow Jersey PR	www.yellowjerseypr.com
Charles Goodwin/Abena Affum/Katie Bairsto	+44 (0) 7747 788 221

 

About LightwaveRF

 

LightwaveRF plc ("LightwaveRF" or the "Company") pioneered smart home automation with the introduction of the market's first internet enabled devices in 2008. Today, the Company offers a market leading proprietary Internet of Things ("IoT") platform together with applications and connected devices, which provide fully integrated remote control and monitoring of light, heat, power and security. We are dedicated to making everyone's lives easier and more fulfilled through world leading smart home technology.

 

For further information and to sign up for investor news alerts please visit www.lightwaverf.com/corporate/ 

 

This information is provided by RNS

The company news service from the London Stock Exchange

 

END

 

 

MSCVVLBFDEFBBBE

Close